Study protocol: a prospective single-center study for non-invasive biomonitoring of renal complications in cancer patients treated with immune checkpoint inhibitors.

Baier, Eva; Korsten, Peter; Strauß, Arne; Thoms, Kai-Martin; Overbeck, Tobias; Ströbel, Philipp; Tampe, Björn

Baier, Eva; Korsten, Peter; Strauß, Arne; Thoms, Kai-Martin; Overbeck, Tobias; Ströbel, Philipp; Tampe, Björn.

Afiliação

Baier E; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Strauß A; Department of Urology, University Medical Center Göttingen, Göttingen, Germany.
Thoms KM; Department of Dermatology, University Medical Center Göttingen, Göttingen, Germany.
Overbeck T; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Ströbel P; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
Tampe B; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.

Front Immunol ; 14: 1140677, 2023.

Article em En | MEDLINE | ID: mdl-37180131

Assuntos

Antineoplásicos Imunológicos; Neoplasias; Humanos; Inibidores de Checkpoint Imunológico/efeitos adversos; Antígeno B7-H1/metabolismo; Estudos Prospectivos; Monitoramento Biológico; Antineoplásicos Imunológicos/uso terapêutico; Rim/metabolismo; Estudos Observacionais como Assunto

Palavras-chave

AIN; ICI; PD-L1; TEC; irAE; urinary flow cytometry

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google